Unidad de Investigación, Carlos Méndez del Centro Universitario de Investigaciones Biomédicas de la Universidad de Colima, Av. 25 de Julio 965, CP 28045, Colima, Colima, Mexico.
Pflugers Arch. 2011 Oct;462(4):505-17. doi: 10.1007/s00424-011-0995-5. Epub 2011 Jul 22.
Cardiac inward rectifier potassium currents determine the resting membrane potential and contribute repolarization capacity during phase 3 repolarization. Quinacrine is a cationic amphiphilic drug. In this work, the effects of quinacrine were studied on cardiac Kir channels expressed in HEK 293 cells and on the inward rectifier potassium currents, I(K1) and I(KATP), in cardiac myocytes. We found that quinacrine differentially inhibited Kir channels, Kir6.2 ∼ Kir2.3 > Kir2.1. In addition, we found in cardiac myocytes that quinacrine inhibited I(KATP) > I(K1). We presented evidence that quinacrine displays a double action towards strong inward rectifier Kir2.x channels, i.e., direct pore block and interference in phosphatidylinositol 4,5-bisphosphate, PIP(2)-Kir channel interaction. Pore block is evident in Kir2.1 and 2.3 channels as rapid block; channel block involves residues E224 and E299 facing the cytoplasmic pore of Kir2.1. The interference of the drug with the interaction of Kir2.x and Kir6.2/SUR2A channels and PIP(2) is suggested from four sources of evidence: (1) Slow onset of current block when quinacrine is applied from either the inside or the outside of the channel. (2) Mutation of Kir2.3(I213L) and mutation of Kir6.2(C166S) increase their affinity for PIP(2) and lowers its sensitivity for quinacrine. (3) Mutations of Kir2.1(L222I and K182Q) which decreased its affinity for PIP(2) increased its sensitivity for quinacrine. (4) Co-application of quinacrine with PIP(2) lowers quinacrine-mediated current inhibition. In conclusion, our data demonstrate how an old drug provides insight into a dual a blocking mechanism of Kir carried inward rectifier channels.
内向整流钾电流决定静息膜电位,并在 3 期复极化时贡献复极化能力。奎纳克林是一种阳离子两亲性药物。在这项工作中,研究了奎纳克林对 HEK 293 细胞表达的心脏 Kir 通道和心脏肌细胞内向整流钾电流 I(K1)和 I(KATP)的影响。我们发现奎纳克林对 Kir 通道的抑制作用具有差异性,Kir6.2∼Kir2.3>Kir2.1。此外,我们在心脏肌细胞中发现,奎纳克林抑制 I(KATP)>I(K1)。我们提供的证据表明,奎纳克林对强内向整流 Kir2.x 通道表现出双重作用,即直接孔阻塞和对磷脂酰肌醇 4,5-二磷酸(PIP(2))-Kir 通道相互作用的干扰。Kir2.1 和 2.3 通道中的孔阻塞表现为快速阻塞;通道阻塞涉及面向 Kir2.1 细胞质孔的残基 E224 和 E299。药物与 Kir2.x 和 Kir6.2/SUR2A 通道和 PIP(2)相互作用的干扰来自四个方面的证据:(1)奎纳克林从通道内部或外部施加时,电流阻断的起始缓慢。(2)Kir2.3(I213L)突变和 Kir6.2(C166S)突变增加了它们对 PIP(2)的亲和力,并降低了其对奎纳克林的敏感性。(3)Kir2.1(L222I 和 K182Q)突变降低了其对 PIP(2)的亲和力,增加了其对奎纳克林的敏感性。(4)奎纳克林与 PIP(2)共同应用降低了奎纳克林介导的电流抑制。总之,我们的数据表明,一种旧药物如何提供对 Kir 携带内向整流通道的双重阻断机制的深入了解。